Rchr
J-GLOBAL ID：201801009705254546
Update date: Sep. 01, 2020
Homma Kengo
Homma Kengo
Affiliation and department：
Research field (1)：
Molecular biology
Research keywords (2)：
シグナル伝達
, ストレス応答
Papers (11)：
-
Naomi Tsuburaya, Kengo Homma, Tsunehiko Higuchi, Andrii Balia, Hiroyuki Yamakoshi, Norio Shibata, Seiichi Nakamura, Hidehiko Nakagawa, Shin-ichi Ikeda, Naoki Umezawa, et al. A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse model. NATURE COMMUNICATIONS. 2018. 9. 1
-
Keiko Imamura, Yuishin Izumi, Akira Watanabe, Kayoko Tsukita, Knut Woltjen, Takuya Yamamoto, Akitsu Hotta, Takayuki Kondo, Shiho Kitaoka, Akira Ohta, et al. The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. SCIENCE TRANSLATIONAL MEDICINE. 2017. 9. 391. eaaf3962
-
Takao Fujisawa, Motoo Takahashi, Yuka Tsukamoto, Namiko Yamaguchi, Masayoshi Nakoji, Megumi Endo, Hiroshi Kodaira, Yuki Hayashi, Hideki Nishitoh, Isao Naguro, et al. The ASK1-specific inhibitors K811 and K812 prolong survival in a mouse model of amyotrophic lateral sclerosis. HUMAN MOLECULAR GENETICS. 2016. 25. 2. 245-253
-
Atsushi Tsubota, Hidenori Ichijo, Kengo Homma. Mislocalization, aggregation formation and defect in proteolysis in ALS. AIMS Molecular Science. 2016. 3. 2. 246
-
Yuki Hayashi, Kengo Homma, Hidenori Ichijo. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Advances in Biological Regulation. 2016. 60. 95-104
ｍore...
Professional career (1)：
Work history (4)：
- 2018/05 - 現在 Tokyo Medical and Dental University Medical Research Institute
- 2018/02 - 2018/04 The University of Tokyo
- 2017/04 - 2018/01 理化学研究所 創薬細胞基盤開発
- 2013/04 - 2017/03 The University of Tokyo
Return to Previous Page
